Vertex Pharmaceuticals

VRTX

HealthcareNMS$115.6B

VRTX SEC filings last scanned 4 Oct 2026, 18:58 UTC

CEO Timeline

Dr. Reshma KewalramaniCurrent

Apr 2020 — Present(6y 6mo)

Dr. Reshma Kewalramani was appointed President and Chief Executive Officer of Vertex Pharmaceuticals Incorporated, effective April 1, 2020.

1 source filing — click to expand

Jeffrey M. Leiden

Feb 2012 — Apr 2020(8y 2mo)

Dr. Jeffrey M. Leiden was appointed President and Chief Executive Officer of Vertex Pharmaceuticals, effective February 1, 2012, succeeding Matthew W. Emmens.

transitioned to Executive Chairman role

4 source filings — click to expand

Matthew Emmens

May 2009 — Feb 2012(2y 9mo)

Matthew Emmens was appointed Chief Executive Officer and Chairman of Vertex Pharmaceuticals, effective May 23, 2009, succeeding Joshua S. Boger.

planned transition to Executive Chairman, with planned retirement on May 22, 2012

3 source filings — click to expand

Joshua S. Boger

Since at least Feb 2005 — May 2009(4y 3mo)

transition agreement effective May 23, 2009

2 source filings — click to expand